News 14 Nov 2023 Opening of the Dynamic Imaging Center at sitem-insel in Bern sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.
Aktuell 06 Dic 2023 Philochem startet Studie für Tumorbildgebung Philochem und Blue Earth Diagnostics haben in ihrer Phase-1-Studie die ersten drei Patienten untersucht. Die Studie dient der Entwicklung eines k...
Actualités 14 Nov 2023 Ouverture du « Dynamic Imaging Center » au sitem-insel à Berne sitem-insel a inauguré le « Dynamic Imaging Center », une installation révolutionnaire qui propose une nouvelle approche de l'imagerie par rayons...
News 06 Dic 2023 Philochem launches clinical trial for tumor imaging Philochem and Blue Earth Diagnostics have examined their first three patients as part of a Phase 1 clinical trial. The trial aims to develop a sm...
News 15 Nov 2023 Aktiia’s blood pressure monitoring technology advances global cardiovascular research Neuchâtel start-up Aktiia, a pioneer in cuffless blood pressure monitoring, has embarked on a groundbreaking study in collaboration with eminent ...
Actualités 15 Nov 2023 La technologie d’Aktiia fait progresser la recherche cardiovasculaire mondiale La start-up neuchâteloise Aktiia, pionnière de la surveillance de la pression artérielle sans brassard, s’est lancée dans une étude inédite en co...
Actualités 13 Nov 2023 Berne en passe de devenir un hub medtech de classe mondiale d’ici 2030 Le canton de Berne s’est donné pour mission de devenir un centre médical mondial de premier plan d’ici à 2030. En rassemblant une expertise médic...
News 13 Nov 2023 Bern’s journey to becoming a world-class medtech hub by 2030 The canton of Bern is on a mission to become a leading global medical hub by 2030. By combining an exceptional medical expertise medical expertis...
News 02 Nov 2023 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.
Actualités 03 Nov 2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
Actualités 02 Nov 2023 Quatre start-ups genevoises innovantes reçoivent le soutien du FIF Le FIF a soutenu quatre start-ups prometteuses pour favoriser l’innovation dans le cadre des Objectifs de Développement Durable de l’ONU.
News 18 Ott 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
News 03 Nov 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 18 Ott 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
Factsheet 04 Dic 2023 Contenuti dei partner: gestione e riciclaggio dei rifiuti in Nigeria La Nigeria è uno dei Paesi più inquinati al mondo. Tanto che le risorse e i mezzi di sussistenza sono a rischio. Tuttavia, l’enorme volume di rif...
Actualités 11 Ott 2023 Orio Therapeutics s’associe à la plus grande université d’Australie pour transformer la médecine régénérative Dans le but de redéfinir la médecine régénérative, l'Université Monash collabore avec la société valaisanne Orio Therapeutics pour innover dans l...
News 11 Ott 2023 Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine In a stride towards redefining regenerative medicine, Monash University collaborates with Valais-based Orio Therapeutics to innovate in the realm...
News 16 Ott 2023 Adiposs completes the phase I clinical trial of its flagship product ImageBAT Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...